Tigermed expands footprint and services by acquiring Marti Farm
Tigermed a full-service Hangzhou CRO has acquired Marti Farm, a European CRO based in Zagreb, Croatia.
Marti Farm offers pharmacovigilance, clinical operations and regulatory services to pharma and cosmetic companies. Over the past 12 years, it has worked with 150 companies in 50 countries.
Tigermed said it expects the acquisition will increase its presence in Europe, offering clinical research organization (CRO) services to biopharmas, while it expands Marti Farm’s cloud-based pharmacovigilance capabilities to global clients.
The terms of the acquisition were not disclosed.
Marti Farm is known for providing regulatory services for pharmaceuticals, biotechnology, medical devices, and food supplements.
The company’s cloud-based pharmacovigilance system is used by more than 100 companies to ensure drug safety.
"We are truly excited to join Tigermed and collaborate with our new partners to deliver innovative patient outcomes." Said Martina Diminić Smetiško, founder and CEO of Marti Farm.
"We believe Marti Farm is well-positioned to not only provide local professional expertise and services but also contribute to building up the Tigermed global platform to serve healthcare innovation globally."
"We are delighted to have Marti Farm in the Tigermed family to further strengthen service offerings in Europe and expand our global presence," said Michael Wen, executive vice president and head of Tigermed International Business.
"By bringing Marti Farm's deep knowledge and expertise to the table, we will continue to offer high-quality clinical trial solutions and meet patients' unmet medical needs."
Tigermed offers a portfolio of services that range from preclinical development to clinical trials and commercialization. The company has a global network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees in 54 countries in Asia Pacific, Europe, North & South America, and Africa.
Unsplash/NielsBosman